Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (401) Lovenox (enoxaparin sodium) Injection, Rhone Poulenc Rorer,
...Newly Approved Drug Therapies (401) Lovenox (enoxaparin sodium) Injection, Rhone Poulenc Rorer, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Lovenox (enoxaparin sodium) Injection Company: Rhone Poulenc Rorer Approval Status: Approved February 1998 Treatment Area: prevention ...
View Page

2.  Newly Approved Drug Therapies (259) Lovenox (enoxaparin sodium) Injection, Rhone Poulenc Rorer,
...Newly Approved Drug Therapies (259) Lovenox (enoxaparin sodium) Injection, Rhone Poulenc Rorer, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Lovenox (enoxaparin sodium) Injection Company: Rhone Poulenc Rorer Approval Status: Approved May 1997 Treatment Area: deep ...
View Page

3.  Newly Approved Drug Therapies (551) Lovenox (enoxaparin sodium) Injection, Rhone Poulenc Rorer,
...Newly Approved Drug Therapies (551) Lovenox (enoxaparin sodium) Injection, Rhone Poulenc Rorer, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Lovenox (enoxaparin sodium) Injection Company: Rhone Poulenc Rorer Approval Status: Approved January 1999 Treatment Area: Hematology ...
View Page

4.  CenterWatch: New Medical Therapies in Disease Category (463), Myocardial Infarction (Heart Attack)
...phase III trials. Sanofi-Aventis issued positive long-term results from two clinical trials of Lovenox for the treatment of acute ST-segment elevation myocardial infarction (STEMI). The first trial, dubbed ...
...Infarction -- Study 25), enrolled 4,676 subjects. The subjects received adjunctive anticoagulation therapy with either Lovenox or unfractionated heparin (UFH) in a blinded fashion during fibrinolysis and underwent subsequent percutaneous coronary ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (281), Heart Failure
...phase III trials. Sanofi-Aventis issued positive long-term results from two clinical trials of Lovenox for the treatment of acute ST-segment elevation myocardial infarction (STEMI). The first trial, dubbed ...
...Infarction -- Study 25), enrolled 4,676 subjects. The subjects received adjunctive anticoagulation therapy with either Lovenox or unfractionated heparin (UFH) in a blinded fashion during fibrinolysis and underwent subsequent percutaneous coronary ...
View Page

6.  CenterWatch: New Medical Therapies in Disease Category (676), Dyslipidemia
...phase III trials. Sanofi-Aventis issued positive long-term results from two clinical trials of Lovenox for the treatment of acute ST-segment elevation myocardial infarction (STEMI). The first trial, dubbed ...
...Infarction -- Study 25), enrolled 4,676 subjects. The subjects received adjunctive anticoagulation therapy with either Lovenox or unfractionated heparin (UFH) in a blinded fashion during fibrinolysis and underwent subsequent percutaneous coronary ...
View Page

7.  Study Posting (1570) Trial #156500, Thrombosis, Morristown, NJ
...within patients hospitalized for acute medical illness, and to learn how apixaban compares to enoxaparin (Lovenox®) for preventing these clots. The safety of apixaban will also be studied. Patient Inclusion Criteria ...
View Page

8.  CenterWatch: Hematology Approved Drug Therapies
...1999 Fragmin ; Pharmacia & Upjohn; Treatment of prophylaxis of deep vein thrombosis (DVT), Approved March 1999 Lovenox (enoxaparin sodium) Injection ; Rhone Poulenc Rorer; Treatment for acute deep vein thrombosis, Approved January 1999 ...
...cell anemia, Approved March 1998 Glucagon ; Eli Lilly; Treatment for severe Hypoglycemia, Approved September 1998 Lovenox (enoxaparin sodium) Injection ; Rhone Poulenc Rorer; Treatment for prevention of blood clots following hip-replacement ...
View Page

9.  CenterWatch: New Medical Therapies in Disease Category (315), Hip Replacement
...trial show that Emisphere Technologies' oral heparin did not demonstrate superior efficacy compared to Aventis' Lovenox (enoxaparin) in preventing deep vein thrombosis (DVT). The PROTECT trial included 2,288 subjects undergoing ...
...safety for oral heparin dosed postoperatively in a 30-day treatment regimen compared to injectable Lovenox dosed for a 10-day regimen. Total DVTs were determined by bilateral venography at 30 ...
View Page

10.  CenterWatch: New Medical Therapies in Disease Category (147), Thrombosis
...received 15 or 40 mg of PRT054021 orally twice a day or 30 mg of Lovenox (enoxaparin) subcutaneously twice a day, for 10-14 days. The primary efficacy endpoint was incidence ...
...trial show that Emisphere Technologies' oral heparin did not demonstrate superior efficacy compared to Aventis' Lovenox (enoxaparin) in preventing deep vein thrombosis (DVT). The PROTECT trial included 2,288 subjects undergoing ...
View Page

11.  CenterWatch: List of Newly Approved Drug Thearapies
...cell anemia, Approved March 1998 Glucagon ; Eli Lilly; Treatment for severe Hypoglycemia, Approved September 1998 Lovenox (enoxaparin sodium) Injection ; Rhone Poulenc Rorer; Treatment for prevention of blood clots following hip-replacement ...
...mg tablets, Approved May 1998 Lodine XL (etodolac) ; Wyeth; Treatment for arthritis, Approved February 1998 Lovenox (enoxaparin sodium) Injection ; Rhone Poulenc Rorer; Treatment for prevention of blood clots following hip-replacement ...
View Page

12.  CenterWatch: New Medical Therapies in Disease Category (316), Knee Replacement
...received 15 or 40 mg of PRT054021 orally twice a day or 30 mg of Lovenox (enoxaparin) subcutaneously twice a day, for 10-14 days. The primary efficacy endpoint was incidence ...
View Page

13.  CenterWatch: Musculoskeletal Approved Drug Therapies
...mg tablets, Approved May 1998 Lodine XL (etodolac) ; Wyeth; Treatment for arthritis, Approved February 1998 Lovenox (enoxaparin sodium) Injection ; Rhone Poulenc Rorer; Treatment for prevention of blood clots following hip-replacement ...
View Page

14.  CenterWatch: List of Newly Approved Drug Thearapies
...1999 Fragmin ; Pharmacia & Upjohn; Treatment of prophylaxis of deep vein thrombosis (DVT), Approved March 1999 Lovenox (enoxaparin sodium) Injection ; Rhone Poulenc Rorer; Treatment for acute deep vein thrombosis, Approved January 1999 ...
View Page

15.  CenterWatch: List of Newly Approved Drug Thearapies
...PresTab, Approved December 1997 Glyburide Tablets ; Roche; Treatment for blood-glucose lowering, Approved December 1997 Lovenox (enoxaparin sodium) Injection ; Rhone Poulenc Rorer; Treatment for deep vein thrombosis, Approved May 1997 Neumega ...
View Page